Search
for

    Did you mean CP-690550?
    GlossaryTofacitinib (CP-690550)

    inhibits Janus kinase enzymes to treat autoimmune conditions

    Tofacitinib, also known by the brand name Xeljanz, is a medication that inhibits Janus kinase (JAK) enzymes, which play a role in the inflammatory process. It is used to treat autoimmune conditions such as rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis, and has also shown promise in treating alopecia areata, a condition that causes hair loss.

    Related Terms

    Sort by

    Community Join

    25 / 25 results